Chinese artificial intelligence firm
Baichuan will angle its AI models toward helping doctors and researchers on diagnosis and treatment while propelling advances in clinical medicine and epidemiology, founder and Chief Executive Officer Wang Xiaochuan said in an open letter published on the second anniversary of his company.
The pivot underscores how DeepSeek has up-ended the industry since it demonstrated a low-cost but capable model in January. Some industry executives expect a
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.